Cannaboids May Be Reclassified as Marijuana

Why It Matters

A little-noticed provision buried in a federal spending bill is poised to reshape the American hemp industry, and the clock is running out.

The hemp statutory definition, which has governed what separates a legal agricultural crop from a federally controlled substance since 2018, was fundamentally rewritten by the FY2026 Agriculture Appropriations Act. The change, enacted last November, takes effect on November 12, 2026. When it does, a wide swath of products currently sold legally in gas stations, dispensaries, and online storefronts (such as gummies, drinks, candies infused with delta-8 THC and other cannabinoids) may suddenly be reclassified as marijuana under federal law.

The central tension is straightforward: Congress legalized hemp eight years ago with a definition that turned out to have a hole in it large enough to drive an entire unregulated industry through. Now lawmakers have patched it, and the consequences for farmers, businesses, consumers, and federal agencies are only beginning to come into focus.

The Big Picture

The Statutory Definition

To understand why Congress acted, it helps to understand what the original rule actually said. The Agriculture Improvement Act of 2018, commonly known as the 2018 Farm Bill, removed hemp from the Controlled Substances Act's Schedule I classification, where it had sat alongside marijuana since 1970. The law defined hemp as cannabis containing no more than 0.3% delta-9 THC on a dry weight basis. That single phrase "delta-9 THC" became the fault line.

Hemp and marijuana come from the same plant species, Cannabis sativa. Delta-9 THC is the primary psychoactive compound in cannabis, but it is not the only one. Other THC variants, including delta-8 THC and tetrahydrocannabinolic acid, known as THCA, are also present in the plant and can produce intoxicating effects. Because the 2018 definition only capped delta-9 THC, products could legally contain significant concentrations of these other psychoactive compounds and still qualify as hemp.

This became known as the "farm bill loophole," and the market that emerged from it was substantial. Products marketed as hemp-derived, packaged in formats nearly identical to mainstream snack foods, flooded retail shelves. State attorneys general and regulators grew alarmed. The Cannabis Regulators Association pushed Congress to act. And for two consecutive Congresses, lawmakers tried and failed to close the gap.

Hemp Legislation 2026

The 118th Congress considered but did not enact changes to the hemp definition. The 119th Congress picked up where its predecessor left off, with both the House and Senate Agriculture appropriations committees advancing bills that would tighten the standard. The debate dragged on for months. An amendment, Senate Amendment 3941, was introduced specifically to strip the hemp provision from the final package. It was tabled.

What emerged was a significant rewrite of agricultural hemp policy. The FY2026 Agriculture Appropriations Act amended the statutory definition of hemp in one decisive way: it replaced the 0.3% delta-9 THC cap with a 0.3% total THC cap. Every psychoactive THC variant now counts toward the threshold, not just delta-9.

The hemp definition Congress changes also introduced a new category, "industrial hemp," explicitly defined to include hemp grown for use of its stalk, grain, oil, fiber, and other non-cannabinoid derivatives, as well as immature plants like microgreens and hemp grown for research that does not enter commerce. Traditional agricultural uses of the plant are protected. The intoxicating cannabinoid products are not.

The new law also creates a series of explicit exclusions. Products containing cannabinoids that cannot be naturally produced by a cannabis plant are excluded from the hemp definition entirely. So are intermediate hemp-derived cannabinoid products (those not yet in their final form or intended to be mixed with another substance) that exceed 0.3% combined total THC and similar-effect cannabinoids. Under the hemp regulatory changes, these products revert to regulation as marijuana under the Controlled Substances Act.

Political Stakes

The Administration

The Trump administration inherited a ticking clock. USDA must overhaul its Domestic Hemp Production Program before November 12, 2026, to align with the new total THC standard.

Law enforcement and public health advocates who pushed for the change now expect aggressive implementation. Hemp industry groups, who opposed the definitional changes in P.L. 119-37 and argued that the market should instead be regulated through agencies like the FDA, are not going quietly. Several bills already introduced in the 119th Congress would delay the effective date by two additional years, repeal the changes outright, or carve out alternative frameworks.

For the GOP, the hemp definition Congress changes present an awkward collision between agricultural constituency interests and a law-and-order policy posture. Hemp farmers who built businesses around the old standard, and whose crops may now test non-compliant under a total THC measurement, are a real political constituency in farm-state districts. The new rules could put some of them in legal jeopardy through no deliberate wrongdoing.

For Democrats, the issue cuts differently. Supporting tighter regulation of intoxicating products appeals to public health instincts, but the economic disruption to small farmers and the lack of a comprehensive FDA regulatory framework leave a policy vacuum that critics can exploit.

For the public, the stakes are most immediate in the consumer market. Products that have been purchased legally for years may be reclassified as controlled substances in a matter of months, with little public awareness that the rules have changed.

The FDA Problem

One of the most concrete warning signs in the CRS report involves the FDA. Under P.L. 119-37, the agency was required to publish, within 90 days of the law's enactment, a list of all cannabinoids known to be naturally produced in a cannabis plant, a list of THC-class cannabinoids, and a list of other cannabinoids with effects similar to THC. As of late May 2026, that publication had not appeared.

The missed deadline matters because the new hemp statutory definition's exclusions hinge on whether a given cannabinoid can be "naturally produced" by a cannabis plant. Without the FDA's list, industry compliance is operating in a fog. Producers, retailers, and law enforcement all need that guidance to understand where the new legal lines fall, and the administration's failure to deliver it on time raises questions about whether implementation is being treated with the urgency the November deadline demands.

The Bottom Line

The hemp regulatory changes enacted through the FY2026 Agriculture Appropriations Act represent the most significant overhaul of federal hemp policy since the 2018 Farm Bill created the legal hemp industry in the first place. By shifting the threshold from delta-9 THC alone to total THC, Congress closed the loophole that allowed a largely unregulated market in intoxicating cannabinoid products to flourish under the cover of agricultural hemp policy.

Two things above all else define what comes next. First, the November 12, 2026, effective date is a hard legal deadline, and USDA, FDA, and DEA all have work to do before it arrives. The FDA's already-missed publication deadline is an early indicator of whether the administration is treating this as the priority Congress intended it to be.

Second, the legislative fight is not over. Multiple bills in the 119th Congress would delay, repeal, or substantially revise what was just enacted. The hemp industry has allies on Capitol Hill, and the outcome of those efforts will determine whether November 12 marks a genuine turning point in federal cannabis policy or merely another chapter in a long-running regulatory standoff.